Financials

Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM

Halozyme Therapeutics Inc

Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment. The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California.

ニュース